Hva Skjer’a ?
Denne tråden er stengt for nye innlegg.
01.10.2021 kl 16:07
225000 aksjer omsatt før 09:10 på stigende priser på en «negativ børsdag»....
Her er det definitivt noe som skjer - stay tuned...
Her er det definitivt noe som skjer - stay tuned...
Redigert 15.09.2021 kl 17:36
Du må logge inn for å svare
xjack
21.04.2021 kl 16:10
4766
Tenker det, Carrera! Imidlertid håper han nok at det bankes ut en større gruppe troløse aksjonærer som ligger på ank. TM tok jo store jafs på 37,5 (fjorårets emisjon). På linje med oss andre som fremdeles tror godt om BgBios muligheter, så ser han nok verdien av å få snittet ned inngangen. (Selv om noen lusne kroner har minimal betydningen, når kursutviklingen skal mot 250 innen neste års pinse - som spådd her på forum, he,he)
BioBull
21.04.2021 kl 16:43
4590
Carrera skrev Er det ikke nå Trond Mohn skal shoppe litt da?
😎Buy On Dips...
En liten fugl har visket i mitt øre ...
«Når den siste pessimist blir optimist - da snur kursen i BGBIO også...»
I morgen er det Arctic presentasjon - jeg håper vi får en større forståelse for at kursen på BGBIO hører hjemme nærmere 60 NOK enn 30 NOK.
Det er sikkert mye ledelsen i BGBIO gjerne skulle sagt, men jeg tenker/håper/tror og forventer at de snart får grunnlag til å komme med tydelige meldinger!
Fikk dessverre alt for få aksjer under 28,50 NOK idag,-, jeg også ...
Får aldri nok aksjer i BGBIO ...😎
En liten fugl har visket i mitt øre ...
«Når den siste pessimist blir optimist - da snur kursen i BGBIO også...»
I morgen er det Arctic presentasjon - jeg håper vi får en større forståelse for at kursen på BGBIO hører hjemme nærmere 60 NOK enn 30 NOK.
Det er sikkert mye ledelsen i BGBIO gjerne skulle sagt, men jeg tenker/håper/tror og forventer at de snart får grunnlag til å komme med tydelige meldinger!
Fikk dessverre alt for få aksjer under 28,50 NOK idag,-, jeg også ...
Får aldri nok aksjer i BGBIO ...😎
BioBull
21.04.2021 kl 16:46
4557
250 NOK ...🤣 Lenge før Pinse 2022 -
( er du pessimist 🤔eller bare religiøs 😇)
( er du pessimist 🤔eller bare religiøs 😇)
Besta
21.04.2021 kl 16:50
4565
Picosalax skrev Nettopp. Derfor solgte jeg rubbet i går.
Hvorfor er du da fremdeles på dette forumet ??
BioBull
21.04.2021 kl 16:55
4515
Picosalax skrev Nettopp. Derfor solgte jeg rubbet i går.
..takk for info. Alltid greit å vite hvem som var blant de siste pessimistene i BGBIO... regner med / tror på / håper på at det var en elendig beslutning av deg. Vil anbefale deg å kjøpe deg opp i natt ...🤔
Yngling ØH
21.04.2021 kl 16:58
4488
Lordstock skrev Nogen med link til dagens presentation ?
Presentasjonen er i morgen kl 14:05
Yngling ØH
21.04.2021 kl 17:03
4411
Besta skrev Hvorfor er du da fremdeles på dette forumet ??
Jeg håper det er lov å være både positiv og negativ? Og både kjøpe og selge? Man blir ikke klokere av å sitte i et ekkokammer.
Husk at hver gang du kjøper en aksje, så er det noe som selger. Hver gang du selger, så er det noen som kjøper. Begge deler er vel greit?
Det blir noe annet om man stadig vekk legger ut villedende informasjon, usanne påstander osv.
Husk at hver gang du kjøper en aksje, så er det noe som selger. Hver gang du selger, så er det noen som kjøper. Begge deler er vel greit?
Det blir noe annet om man stadig vekk legger ut villedende informasjon, usanne påstander osv.
focuss
21.04.2021 kl 17:11
4320
Slettet brukerskrevInnlegget er slettet
Så få deltagere da. Er ikke selskapene interessert i å delta hos Arctic? Stinker det for mye?
peaf
21.04.2021 kl 17:12
4296
Ja om Godfrey seier att noe er lovende så er det bare selge, det er beviseligt tap har det vist seg.
Hildebart
21.04.2021 kl 17:14
4257
Besta skrev Hvorfor er du da fremdeles på dette forumet ??
Man må da få lov til å følge og diskutere en aksje selv om man ikke eier den. Kanskje man fanger opp ny informasjon som gjør at man ønsker å kjøpe seg inn på nytt? Kanskje man har noe å bidra med slik at andre ser at se bør selge eller kjøpe?
Det er flere her som ønsker et forum kun for eiere av en aksje. Og disse eierne skal utelukkende skrive positivt om aksjen. Det er helt absurd. Hva om man sitter short i en aksje? Da bør man vel få lov til å fremme synspunkt som underbygger grunnen til at man faktisk sitter short? Alt dette forutsetter jo selvsagt at man underbygger påstander med fakta.
Det er flere her som ønsker et forum kun for eiere av en aksje. Og disse eierne skal utelukkende skrive positivt om aksjen. Det er helt absurd. Hva om man sitter short i en aksje? Da bør man vel få lov til å fremme synspunkt som underbygger grunnen til at man faktisk sitter short? Alt dette forutsetter jo selvsagt at man underbygger påstander med fakta.
focuss
21.04.2021 kl 17:20
4229
YØH
"Det blir noe annet om man stadig vekk legger ut villedende informasjon, usanne påstander osv."
Det er jo nettopp dette du har drevet med i lang tid som stadig flere forstår. Antar du blir den siste som innser det. Du kaller skribenter som er uenig med deg for løgnere og stenger dem ute da de ikke passer i ditt ekkokammer. Shame on you.
PS. Til orientering. Du skjønner jo ikke forskjell på hva som er viktig og hva som er bagateller. Det har ført mange bak lyset.
"Det blir noe annet om man stadig vekk legger ut villedende informasjon, usanne påstander osv."
Det er jo nettopp dette du har drevet med i lang tid som stadig flere forstår. Antar du blir den siste som innser det. Du kaller skribenter som er uenig med deg for løgnere og stenger dem ute da de ikke passer i ditt ekkokammer. Shame on you.
PS. Til orientering. Du skjønner jo ikke forskjell på hva som er viktig og hva som er bagateller. Det har ført mange bak lyset.
Redigert 21.04.2021 kl 17:21
Du må logge inn for å svare
Pjusken_
21.04.2021 kl 17:27
4180
Dette er nok sydd sammen på kort varsel uten å involvere noen direkte utenlandske selskap. Bra initiativ!
Bra de har lagt til Q&A også. Vi får nok ikke grensesprengende nyheter, men kanskje noe mer forståelse for prosessen videre.
Jeg reagerer heller på påmelding via epost..vil de ha begrenset tilgang av en grunn? Ikke sett det før..vanlig med påmelding via link. Men igjen..kort varsel.
Bra de har lagt til Q&A også. Vi får nok ikke grensesprengende nyheter, men kanskje noe mer forståelse for prosessen videre.
Jeg reagerer heller på påmelding via epost..vil de ha begrenset tilgang av en grunn? Ikke sett det før..vanlig med påmelding via link. Men igjen..kort varsel.
focuss
21.04.2021 kl 17:46
4075
Skal man investere i biotech så er punkt 1A. Kan man stole på CEO?. Hvis nei: Hold deg unna. Dette skjønner de fleste i den posisjonen, men det finnes unntak.
Ny presentasjon..Det betyr vel at kursen skal enda lenger ned. Kommunikasjonen fra CEO er det jo ingen som forstår allikevel .Om de har noe stort på gang så trenger de en som kan formidle det så allmennheten forstår det. Har vært aksjonær her i vel 3 år og ingen ting er forandret. Det er ikke alltid tålmodighet lønner seg....
Besta
21.04.2021 kl 17:59
3965
Legger meg flat og innrømmer at det var en lite gjennomtenkt kommentar.
focuss
21.04.2021 kl 18:09
3877
Jeg tror at det Godfrey må konsentrere seg om nå er å finne ut av hva strategien skal være for å komme raskest mulig til markedet med potensiell kreftmedisin. Foreløpig så er jo alt ut som et kaos uten mål og mening. Hva er prioriteringen, og hva er strategien. Så langt uten klar mål og mening og å vurdere verdien synes rett og slett basert på tenk på et tall. Tror Godfrey må være skarpere i å definere veien fremover.
Carrera
21.04.2021 kl 18:18
3827
Du stoler jo ikke på Godfrey - men du har jo ikke holdt deg unna ???????
Talent
21.04.2021 kl 18:18
3804
Hvorfor holder ikke du deg unna da? Det er for at du er ut og inn av aksjen hele tiden
Carrera skrevInnlegget er slettet
De aller fleste som er aksjonær har nok tro på selskapet, men formidlingen burde være mye bedre til markedet. Og noen her på forumet må nok dempe sin optimisme en smule. Samme platen oppatt og oppatt.
focuss
21.04.2021 kl 19:21
3569
focuss skrevInnlegget er slettet
Og det har absolutt ingen verdi for de som undres over om man ønsker superavkastning om BGBIO er stedet å være. Han kjenner jo ingen andre selskap.
focuss
21.04.2021 kl 19:38
3489
Burde jeg takke Godfrey for at han la ut en manipulerende presentasjon på hjemmesiden som ga meg anledning til å selge aksjene mine langt over dagens kurs? Nei jeg synes ikke det, rett og slett for at det at det er skadelig for børsens renome`. Man kan jo spørre, var det mange av hans venner å bekjente som solgte på 34 -35 slik jeg gjordet? Bare trist med slikt.
Lakshmi
21.04.2021 kl 19:44
3488
focuss skrevInnlegget er slettet
Bare det at her er så mye meninger og diskusjoner rundt BergenBio, det sier at her bør du for din egen del være inne.
Det skulle bare mangle..Men det kommer stadig nye uerfarne som leser forumet. De investerer mye på grunn av forumet og da mener jeg vi har ett ansvar. Jeg har stor tro på selskapet. Men det er ikke sakt at jeg har rett for det. Vi trenger en motpol som foccus,kanskje han får rett.....Ingen ting er bevist så langt. Men har troen.
Yngling ØH
21.04.2021 kl 20:05
3522
Det er ganske omfattende beskyldninger mot India i forhold til mulig underrapportering av dødsfall.
"Non-stop cremations cast doubt on India's counting of COVID dead"
""We are working around the clock at 100% capacity to cremate bodies on time," Kamlesh Sailor, the president of the trust that runs the crematorium in the diamond-polishing city of Surat, told Reuters.
And with hospitals full and oxygen and medicines in short supply in an already creaky health system, several major cities are reporting far larger numbers of cremations and burials under coronavirus protocols than official COVID-19 death tolls, according to crematorium and cemetery workers, media and a review of government data."
https://www.reuters.com/world/india/non-stop-cremations-cast-doubt-indias-counting-covid-dead-2021-04-19/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508490/
"In the western state of Gujarat, for instance, regional-language media has been upfront in its criticism of the government, which has been accused of downplaying the Covid-19 situation. The high court in Gujarat has also filed a suo moto case and asked the government to explain how its numbers are grossly different from people’s accounts of the rise in infections and deaths.
For instance, in Gujarat’s merchant town Surat, crematoriums have been working overtime. A metal grill on the furnace at one such crematorium melted because of round-the-clock use, a macabre proof of the sharp rise fatalities.
And yet, the city of Surat has been reporting under 20 deaths a day. “Before the coronavirus outbreak last year, around 20 bodies were cremated at the Kurukshetra Crematorium (in Surat) every day,” Kamlesh Sailor, president of a trust which manages the crematorium, told the Press Trust of India on April 13. “Now, there is a sudden rush of bodies. At present, we are handling about 100 bodies per day.”
According to local news reports, all 16 gas-based crematoriums in the city have been operating at capacity without a break.
This underreporting of deaths is being contested in other states, too.
Covid-19 crematoriums overworked
The central state of Madhya Pradesh reported 37 deaths on April 12. Yet, in its capital city Bhopal alone, there were 37 funerals at one single crematorium the same day, NDTV reported. On some days, the Covid-19 funerals at a single crematorium exceeded the total death toll of the entire state.
Officials at the crematoriums in Bhopal told NDTV that they haven’t seen such long queues of ambulances waiting their turn for funerals since the 1984 gas tragedy in the city. “I am feeling weak, getting tired… too many dead bodies are coming in and it is crowded here. We can’t even take a break for lunch,” Pradeep Kanojia, a worker at the Bhopal crematorium, told NDTV. The crematorium is now also running short of firewood for the pyres.
In Delhi, which has seen its worst-ever surge in Covid-19 cases at 17,282 on April 14, crematorium workers have complained that the local body has not given sufficient protective gear.
The death figures appear to be suppressed in other states, too.
A sudden surge in deaths
In Uttar Pradesh’s capital Lucknow, there has been a consistent rise in the number of Covid-19 funerals. On April 11, nearly 70 bodies came to one Covid-19 crematorium in the city, leading to a long queue and overworked staff. Yet, the state-wide death figure for one of India’s largest states on the day was 72.
“We were handling 7-8 cremations of Covid patients’ bodies on average per day (combined for the two crematoriums). But in the last one week, the number went up to 30 and then 40. Eventually, 69 bodies came for cremation Sunday,” Ajay Dwivedi, Lucknow’s municipal commissioner, told ThePrint."
https://qz.com/india/1996859/indias-crematoriums-are-overburdened-due-to-covid-19-deaths/
"Non-stop cremations cast doubt on India's counting of COVID dead"
""We are working around the clock at 100% capacity to cremate bodies on time," Kamlesh Sailor, the president of the trust that runs the crematorium in the diamond-polishing city of Surat, told Reuters.
And with hospitals full and oxygen and medicines in short supply in an already creaky health system, several major cities are reporting far larger numbers of cremations and burials under coronavirus protocols than official COVID-19 death tolls, according to crematorium and cemetery workers, media and a review of government data."
https://www.reuters.com/world/india/non-stop-cremations-cast-doubt-indias-counting-covid-dead-2021-04-19/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508490/
"In the western state of Gujarat, for instance, regional-language media has been upfront in its criticism of the government, which has been accused of downplaying the Covid-19 situation. The high court in Gujarat has also filed a suo moto case and asked the government to explain how its numbers are grossly different from people’s accounts of the rise in infections and deaths.
For instance, in Gujarat’s merchant town Surat, crematoriums have been working overtime. A metal grill on the furnace at one such crematorium melted because of round-the-clock use, a macabre proof of the sharp rise fatalities.
And yet, the city of Surat has been reporting under 20 deaths a day. “Before the coronavirus outbreak last year, around 20 bodies were cremated at the Kurukshetra Crematorium (in Surat) every day,” Kamlesh Sailor, president of a trust which manages the crematorium, told the Press Trust of India on April 13. “Now, there is a sudden rush of bodies. At present, we are handling about 100 bodies per day.”
According to local news reports, all 16 gas-based crematoriums in the city have been operating at capacity without a break.
This underreporting of deaths is being contested in other states, too.
Covid-19 crematoriums overworked
The central state of Madhya Pradesh reported 37 deaths on April 12. Yet, in its capital city Bhopal alone, there were 37 funerals at one single crematorium the same day, NDTV reported. On some days, the Covid-19 funerals at a single crematorium exceeded the total death toll of the entire state.
Officials at the crematoriums in Bhopal told NDTV that they haven’t seen such long queues of ambulances waiting their turn for funerals since the 1984 gas tragedy in the city. “I am feeling weak, getting tired… too many dead bodies are coming in and it is crowded here. We can’t even take a break for lunch,” Pradeep Kanojia, a worker at the Bhopal crematorium, told NDTV. The crematorium is now also running short of firewood for the pyres.
In Delhi, which has seen its worst-ever surge in Covid-19 cases at 17,282 on April 14, crematorium workers have complained that the local body has not given sufficient protective gear.
The death figures appear to be suppressed in other states, too.
A sudden surge in deaths
In Uttar Pradesh’s capital Lucknow, there has been a consistent rise in the number of Covid-19 funerals. On April 11, nearly 70 bodies came to one Covid-19 crematorium in the city, leading to a long queue and overworked staff. Yet, the state-wide death figure for one of India’s largest states on the day was 72.
“We were handling 7-8 cremations of Covid patients’ bodies on average per day (combined for the two crematoriums). But in the last one week, the number went up to 30 and then 40. Eventually, 69 bodies came for cremation Sunday,” Ajay Dwivedi, Lucknow’s municipal commissioner, told ThePrint."
https://qz.com/india/1996859/indias-crematoriums-are-overburdened-due-to-covid-19-deaths/
Carrera
21.04.2021 kl 20:06
3557
Lakshmi skrevInnlegget er slettet
En riktig diagnose du gir focuss her - det er vel hjelp å få men problemet med de som har denne diagnosen ikke ser det selv - det er alle andre det er noe feil med.
focuss
21.04.2021 kl 20:08
3579
Lakshmi skrevInnlegget er slettet
Det jeg mener er bare att jeg har mer erfaring i aksjemarkedet og derfor har bedre dømmekraft ikke minst i biotec enn hausserne på BGBIO tråden. Når sant skal sies så skal det ikke mye til. Det har de jo dokumentert med å ha tapt egne penger og følgernes penger i historiens bull marked, mens andre har hatt historiske gevinster.
Men hausserne her har nok en snev av grandiositet i seg når de har pratet folk inn i en taperaksje i et år og fortsatt synes de er fantastiske.
Men hausserne her har nok en snev av grandiositet i seg når de har pratet folk inn i en taperaksje i et år og fortsatt synes de er fantastiske.
Redigert 21.04.2021 kl 20:10
Du må logge inn for å svare
Yngling ØH
21.04.2021 kl 20:12
3583
Experts have questioned shortcomings and lack of clarity in vital registration, testing practices, and classification of COVID-19 deaths. Patralekha Chatterjee reports from New Delhi.
India has had 3·6 million cases of COVID-19, the third most in the world after the USA and Brazil, with 65 288 officially confirmed deaths from the disease as of Sept 1, 2020.
• View related content for this article
The Indian Government says that the national recovery rate has reached 77% and the case fatality rate is down to 1·8%, due to “timely and effective clinical management of the patients in critical care” according to an official statement on Aug 30. However, experts who spoke with The Lancet have pointed to several sources of uncertainty in India's COVID-19 mortality data.
It is unclear how suspected or probable COVID-19-attributable deaths are being included in mortality estimates. Indian Council of Medical Research (ICMR) guidelines stipulate that deaths of people with suspected or probable COVID-19 should be included in mortality data, based on WHO ICD-10 codes for COVID-19-related deaths. However, the guidelines are advisory. Information about whether state data on deaths include suspected and probable cases is not in the public domain and the Indian Ministry of Health and Family Welfare did not respond to The Lancet's requests for clarification.
“For COVID-19, we have to throw the net more widely to capture all the deaths (confirmed and suspected) in order to understand the disease better and for its management” says Prashant Mathur, director of the National Centre for Disease Informatics and Research (NCDIR), an ICMR body. “It is important to correctly record the cause of deaths. But it is up to individual states to follow these guidelines. As per the existing law, NCDIR is not required to get data about suspected or probable deaths from states so I can't say whether deaths are being certified.”
When asked about reports that some states had not recorded any suspected or probable COVID-19 deaths, Giridhara R Babu, an epidemiologist at the Public Health Foundation of India, pointed to general weaknesses in vital registration. He told The Lancet that in rural areas, where most of India's population lives, most deaths occur outside the hospital, which can delay registration. “Among the deaths registered under the civil registration system, only 22% are medically certified nationally with cause of death.”
Rijo John, public health policy analyst and senior fellow at the Centre for Public Policy Research in Kerala, said some under-reporting is happening. He told The Lancet that “while it is true that only 21% of all deaths are medically certified in India, we should not forget that more than 65% of the total COVID-19 deaths reported in India so far are from just four states, Maharashtra, Tamil Nadu, Karnataka, and Delhi. In all these states, the death registration is 100%.”
Babu also highlighted shortcomings in wider surveillance. “[The] Integrated Disease Surveillance System is collecting the data on deaths due to COVID-19 from testing laboratories and hospitals, but misses deaths due to COVID-19 among those who were not tested.” Babu told The Lancet that “verification of data and detailed examination of the death numbers from several hospitals and field offices needs to be done”. He also emphasised the need for data on all-cause mortality to understand the effects of the epidemic. “Patients die due to underlying comorbid conditions and unavailability of critical care.”
Different Indian states are using different COVID-19 diagnostic tests. “Comparing test positive rates between different states has become extremely difficult as more and more states are moving towards rapid antigen detection tests, which are known to have a high percentage of false negatives and not utilising the gold standard RT-PCR tests to full capacity”, said John. Not all states are equally forthcoming with data on how many of each type of test is being used. “Given that we need more resources to scale up testing, knowing the cost-effectiveness of different testing types can be very useful in developing more effective testing guidelines“, he said.
John called on the central government to enforce standards. “Although health is a state responsibility, the health ministry could at least release an advisory to make the data reporting standardised and transparent across states”, he said. “It should be made mandatory for all states to report the break[down] of different test types as well as the positives from these.”
Public pressure and media reports about alleged undercounting have begun to push many states to review their COVID-19 mortality data. “In several states, many of the ‘missing’ deaths were added later on to the tally after audits. For example, Tamil Nadu has added backlogs of 400-plus deaths. So did Maharashtra. West Bengal used to exclude all deaths due to comorbidities from COVID deaths, but they stopped such practices”, John said.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31857-2/fulltext
India has had 3·6 million cases of COVID-19, the third most in the world after the USA and Brazil, with 65 288 officially confirmed deaths from the disease as of Sept 1, 2020.
• View related content for this article
The Indian Government says that the national recovery rate has reached 77% and the case fatality rate is down to 1·8%, due to “timely and effective clinical management of the patients in critical care” according to an official statement on Aug 30. However, experts who spoke with The Lancet have pointed to several sources of uncertainty in India's COVID-19 mortality data.
It is unclear how suspected or probable COVID-19-attributable deaths are being included in mortality estimates. Indian Council of Medical Research (ICMR) guidelines stipulate that deaths of people with suspected or probable COVID-19 should be included in mortality data, based on WHO ICD-10 codes for COVID-19-related deaths. However, the guidelines are advisory. Information about whether state data on deaths include suspected and probable cases is not in the public domain and the Indian Ministry of Health and Family Welfare did not respond to The Lancet's requests for clarification.
“For COVID-19, we have to throw the net more widely to capture all the deaths (confirmed and suspected) in order to understand the disease better and for its management” says Prashant Mathur, director of the National Centre for Disease Informatics and Research (NCDIR), an ICMR body. “It is important to correctly record the cause of deaths. But it is up to individual states to follow these guidelines. As per the existing law, NCDIR is not required to get data about suspected or probable deaths from states so I can't say whether deaths are being certified.”
When asked about reports that some states had not recorded any suspected or probable COVID-19 deaths, Giridhara R Babu, an epidemiologist at the Public Health Foundation of India, pointed to general weaknesses in vital registration. He told The Lancet that in rural areas, where most of India's population lives, most deaths occur outside the hospital, which can delay registration. “Among the deaths registered under the civil registration system, only 22% are medically certified nationally with cause of death.”
Rijo John, public health policy analyst and senior fellow at the Centre for Public Policy Research in Kerala, said some under-reporting is happening. He told The Lancet that “while it is true that only 21% of all deaths are medically certified in India, we should not forget that more than 65% of the total COVID-19 deaths reported in India so far are from just four states, Maharashtra, Tamil Nadu, Karnataka, and Delhi. In all these states, the death registration is 100%.”
Babu also highlighted shortcomings in wider surveillance. “[The] Integrated Disease Surveillance System is collecting the data on deaths due to COVID-19 from testing laboratories and hospitals, but misses deaths due to COVID-19 among those who were not tested.” Babu told The Lancet that “verification of data and detailed examination of the death numbers from several hospitals and field offices needs to be done”. He also emphasised the need for data on all-cause mortality to understand the effects of the epidemic. “Patients die due to underlying comorbid conditions and unavailability of critical care.”
Different Indian states are using different COVID-19 diagnostic tests. “Comparing test positive rates between different states has become extremely difficult as more and more states are moving towards rapid antigen detection tests, which are known to have a high percentage of false negatives and not utilising the gold standard RT-PCR tests to full capacity”, said John. Not all states are equally forthcoming with data on how many of each type of test is being used. “Given that we need more resources to scale up testing, knowing the cost-effectiveness of different testing types can be very useful in developing more effective testing guidelines“, he said.
John called on the central government to enforce standards. “Although health is a state responsibility, the health ministry could at least release an advisory to make the data reporting standardised and transparent across states”, he said. “It should be made mandatory for all states to report the break[down] of different test types as well as the positives from these.”
Public pressure and media reports about alleged undercounting have begun to push many states to review their COVID-19 mortality data. “In several states, many of the ‘missing’ deaths were added later on to the tally after audits. For example, Tamil Nadu has added backlogs of 400-plus deaths. So did Maharashtra. West Bengal used to exclude all deaths due to comorbidities from COVID deaths, but they stopped such practices”, John said.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31857-2/fulltext